Suppression of experimental zymosan-induced arthritis by intraperitoneal administration of adenosine

Drug Development Research

Volumn 57, Issue 4, 2002, Pages 182-186

  Baharav, Ehud ^a   Dubrosin, Anatoly ^a   Fishman, Pnina ^a,b   Bar Yehuda, Sara ^a,b   Halpren, Marisa ^a   Weinberger, Abraham ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Can Fite BioPharma Ltd   (Israel)

Author keywords

Adenosine; Arthritis; Inflammation; TNF ; animal model

Indexed keywords

ADENOSINE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; INFLAMMATORY CELL; LEUKOCYTE COUNT; LYMPH FOLLICLE; MOUSE; NONHUMAN; SYNOVIOCYTE;

EID: 0037000209     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10148     Document Type: Article

References (31)

1. Allegra CJ, Drake JC, Jolivet J, Chabner BA. 1985. Inhibition of phosphoribosyl amino imidazole carboxamide transformylase by Methotrexate and dehydrofolic acid polyglutamates. Proc Natl Acad Sci USA 82:4881-4885.
2. Bodin P, Burnstock G. 1998. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 47:351-354.
3. Bouma MG, Stad RK, van den Wildenberg FAJM, Buurman WA. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 41:59-68.
4. Boyle DL, Kowaluk EA, Jarvis MF, Lee CH, Bhagwat SS, Williams M, Firestein GS. 2001. Anti-inflammatory effect of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J Pharmcol Exp Ther 296:495-500.
5. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. 2002. Methotrexate and mortality in-patients with rheumatoid arthritis: a prospeetive study. Lancet 359:1173-1177.
6. Cronstein BN. 1994. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13.
7. Cronstein BN. 1997. The mechanism of action of methotrexate. Rheum Dis Clin North Am 23:739-755.
8. Cronstein BN, Eberle MA, Gruber HE, Levin RI. 1991. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88:2441-2445.
9. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH. 2001. Antiinflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 60:729-735.
10. Deguchi H, Takeya H, Urano H, Gabazza EC, Zhou H, Suzuki K. 1998. Adenosine regulates tissue factor expression on endothelial cells. Thromb Res 91(2):57-64.
11. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, and Baricordi OR. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600.
12. Eigler A, Matschke V, Hartman G, Erhardt S, Boyle D, Firestein GS, Endres S. 2000. Suppression of TNF-α production in human mononuclear cells by an adenosine kinase inhibitor. J Leuk Bio 168:97-103.
13. Fabris M, Di PE, D'Elia A, Damante G, Sinigaglia L, Ferraccioli G. 2002. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatol 29:29-33.
14. Goldenberg DL, Chisholm PL, Rice PA. 1983. Experimental models of bacterial arthritis: a microbiologic and histopathologic characterization of the arthritis after the intraarticular injections of Neisseria gonorrhoeae, Staphylococcus aureus, group A streptococci, and Escherichia coli. J Rheumatol 1:5-11.
15. Gyllenhammar E, Nordfors LO. 2001. Systemic adenosine infusions alleviated neuropathic pain. Pain 94:121-122.
16. 2A extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90:1600-1610.
17. Keystone EC, Schorlemmer HU, Pope C, Allison AC. 1977. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum 20:1396-1401.
18. 2A receptors in human monocytic THP-1 cells. J Immunol 167:4026-4032.
19. 3 receptor stimulation inhibits migration of human eosinophils. J Leuk Biol 62:465-468.
20. McPherson JA, Barringhaus KG, Bishop GG, Sanders JM, Rieger JM, Hesselbacher SE, Gimple LW, Powers ER, Macdonald T, Sullivan G, Linden J, Sarembock IJ. 2001. Adenosine A (2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 21:791-796.
21. Mirabet M, Herrera C, Cordero OJ, Mallol J, Lluis C, Franco R. 1999. Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J Cell Sci 112:491-502.
22. Nakata H. 1993. Development of an antiserum to rat-brain A1 adenosine receptor: application for immunological and structural comparison of A1 adenosine receptors from various tissues and species. Biochim Biophys Acta 1177(1):93-98.
23. 3 adenosine receptor focus on tumor and normal cell growth. J Cell Physiol 186:19-23.
24. Ohta A, Sitkovsky M. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916-920.
25. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275:4429-34.
26. Stiles GL. 1990. Adenosine receptors and beyond: Molecular mechanisms of physiological regulation. Clin Res 38:10-18.
27. Szabo C, Scott GS, Virag L, Egnaczyk G, Salzman AL, Shanley TP, Hasko G. 1998. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 125:379-387.
28. Taylor PC. 2001. Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Mol Biotechnol 19:153-168.
29. Virag L, Szabo C, 2001. Purines inhibit poly (ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 15:99-107.
30. Wakai A, Wang JH, Winter DC, Street JT, O'Sullivan RG, Redmond HP. 2001. Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation. Shock 15:297-301.
31. Weinberger A, Ben-Gal T, Roizman P, Abramovici A. 1996. Intraarticular minocycline injection in experimental synovitis. Clin Rheumatol 15:290-294.